中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2014年
30期
34-35
,共2页
荧光定量分型PCR法%直接测序法%HBV-DNA
熒光定量分型PCR法%直接測序法%HBV-DNA
형광정량분형PCR법%직접측서법%HBV-DNA
Real-time genotyping and quantitative PCR%Direct sequencing%HBV-DNA
目的:比较荧光定量分型PCR法与直接测序法检测HBV-DNA水平的应用价值。方法选取该院2012年1月-2013年12月收治的126例符合入选标准的HBV患者,分别采用荧光定量分型PCR法与直接测序法检测HBV-DNA水平,对HBV-DNA基因分型结果进行比较分析。结果126份样本只检测出3种基因分型(B型、C型、B/C混合型),其中B型占明显优势。荧光定量分型PCR法B/C混合型检出率明显高于直接测序法(P<0.001)﹔一致性检验表明两种检测方法的一致性较好(Kappa>0.75)﹔TA克隆结果与荧光定量分型PCR法一致。结论荧光定量分型PCR法检测HBV-DNA水平应用价值较直接测序法高,值得临床推广应用。
目的:比較熒光定量分型PCR法與直接測序法檢測HBV-DNA水平的應用價值。方法選取該院2012年1月-2013年12月收治的126例符閤入選標準的HBV患者,分彆採用熒光定量分型PCR法與直接測序法檢測HBV-DNA水平,對HBV-DNA基因分型結果進行比較分析。結果126份樣本隻檢測齣3種基因分型(B型、C型、B/C混閤型),其中B型佔明顯優勢。熒光定量分型PCR法B/C混閤型檢齣率明顯高于直接測序法(P<0.001)﹔一緻性檢驗錶明兩種檢測方法的一緻性較好(Kappa>0.75)﹔TA剋隆結果與熒光定量分型PCR法一緻。結論熒光定量分型PCR法檢測HBV-DNA水平應用價值較直接測序法高,值得臨床推廣應用。
목적:비교형광정량분형PCR법여직접측서법검측HBV-DNA수평적응용개치。방법선취해원2012년1월-2013년12월수치적126례부합입선표준적HBV환자,분별채용형광정량분형PCR법여직접측서법검측HBV-DNA수평,대HBV-DNA기인분형결과진행비교분석。결과126빈양본지검측출3충기인분형(B형、C형、B/C혼합형),기중B형점명현우세。형광정량분형PCR법B/C혼합형검출솔명현고우직접측서법(P<0.001)﹔일치성검험표명량충검측방법적일치성교호(Kappa>0.75)﹔TA극륭결과여형광정량분형PCR법일치。결론형광정량분형PCR법검측HBV-DNA수평응용개치교직접측서법고,치득림상추엄응용。
Objective To compare the application value of real-time genotyping and quantitative PCR with that of direct sequenc-ing for HBV-DNA detection. Methods 126 patients with HBV admitted in our hospital and met the inclusion criteria were select-ed. The levels of HBV-DNA of the patients were detected by real-time genotyping and quantitative PCR and direct sequencing, respectively. And the genotyping results of HBV-DNA were compared and analyzed. Results 3 genotypes (B, C, B/C mixed type) were found in 126 samples, the dominant was type B. The detection rate of B/C mixed type by real-time genotyping and quantitative PCR was higher than direct sequencing (P<0.001). There was a good consistency of two methods (Kappa>0.75). TA cloning results were consistent with real-time genotyping and quantitative PCR. Conclusion The application value of real-time genotyping and quantitative PCR is higher than direct sequencing for HBV-DNA detection, so it is worthy of clinical application and promotion.